C-TIL051 in Anti-PD1 Resistant Metastatic Non-Small Cell Lung Cancer
Clinical Trial Grant
Awarded By
AbelZeta Inc.
Start Date
February 26, 2024
End Date
February 14, 2029
Awarded By
AbelZeta Inc.
Start Date
February 26, 2024
End Date
February 14, 2029